SCHEMBL12355686

SCHEMBL12355686

CCC1Cc2cc3nc(N)n[n+]([O-])c3cc2C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.32
DRD4 P21917 1/20 0.30
DRD3 P35462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2253362 0.86
SCHEMBL2243600 0.84
SCHEMBL2247079 0.84
SCHEMBL12355683 0.83
SCHEMBL12355685 0.83
SCHEMBL12355627 0.81 DRD2 (0.33) DRD2DRD4DRD3
SCHEMBL12355692 0.78
SCHEMBL2246339 0.78 DRD2 (0.35) DRD2
SCHEMBL12355690 0.77
SCHEMBL2247015 0.76 CA12 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989451-B2 Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments AUCKLAND UNISERVICES LIMITED (NZ) 2011-08-02 US disclosed